Clorazepate dipotassium: a new benzodiazepine antianxiety agent.
D000328:Adult; D000368:Aged; D001007:Anxiety / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002264:Carboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D014839:Vomiting / Q000139:chemically induced
D001552:Benzazepines; D002264:Carboxylic Acids; D010919:Placebos